We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+8.13%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$17.4B
AUM Growth
+$2.11B
Cap. Flow
+$1.24B
Cap. Flow %
7.16%
Top 10 Hldgs %
29.6%
Holding
1,504
New
416
Increased
423
Reduced
335
Closed
326

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$125M
2
JNJ icon
Johnson & Johnson
JNJ
+$109M
3
TSLA icon
Tesla
TSLA
+$106M
4
DIS icon
Walt Disney
DIS
+$95.4M
5
KO icon
Coca-Cola
KO
+$79.4M

Sector Composition

Rank Sector Weight
1 Financials 24.18%
2 Industrials 13.69%
3 Energy 13.34%
4 Technology 11.86%
5 Materials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSCR icon
1151
Oscar Health
OSCR
$9.5B
$49K ﹤0.01%
+19,925
New +$62.3K
PSNL icon
1152
Personalis
PSNL
$1.54B
$45.5K ﹤0.01%
22,979
-41,456
-64% -$104K
EIGR
1153
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$44.7K ﹤0.01%
1,263
-359
-22% -$43.1K
FBIO icon
1154
Fortress Biotech
FBIO
$99M
$42.2K ﹤0.01%
4,299
-421
-9% -$4.66K
KRON
1155
DELISTED
Kronos Bio
KRON
$41.7K ﹤0.01%
+25,723
New +$59.2K
GLDG
1156
GoldMining Inc
GLDG
$226M
$41.4K ﹤0.01%
36,400
+18,300
+101% +$19.2K
BHIL
1157
DELISTED
Benson Hill, Inc.
BHIL
$40.7K ﹤0.01%
+456
New +$44.7K
GBIO
1158
DELISTED
Generation Bio
GBIO
$39.3K ﹤0.01%
+1,000
New +$52.5K
SFE
1159
DELISTED
Safeguard Scientifics, Inc.
SFE
$38K ﹤0.01%
12,250
-1,088
-8% -$3.66K
RNAC icon
1160
Cartesian Therapeutics
RNAC
$264M
$30.8K ﹤0.01%
908
-3,987
-81% -$170K
DNTH icon
1161
Dianthus Therapeutics
DNTH
$6.13B
$29.9K ﹤0.01%
4,738
-676
-12% -$12K
TOUR
1162
Tuniu
TOUR
$54.4M
$27.9K ﹤0.01%
+1,851
New +$20.4K
NXDR
1163
Nextdoor Holdings
NXDR
$998M
$27.8K ﹤0.01%
+13,493
New +$31.6K
CANG
1164
Cango Inc
CANG
$92.7M
$27.1K ﹤0.01%
+2,075
New +$42.2K
CIFR icon
1165
Cipher Digital
CIFR
$6.9B
$26.1K ﹤0.01%
+46,683
New +$40.6K
AXDX
1166
DELISTED
Accelerate Diagnostics
AXDX
$21.9K ﹤0.01%
3,100
-3,993
-56% -$43.6K
SPIR icon
1167
Spire Global
SPIR
$540M
$20.9K ﹤0.01%
+2,721
New +$26.6K
HOOK
1168
DELISTED
HOOKIPA Pharma
HOOK
$14.6K ﹤0.01%
1,803
-407
-18% -$4.41K
THER
1169
DELISTED
THERATECHNOLOGIES INC COM
THER
$13.8K ﹤0.01%
+15,600
New +$13.8K
VBIV
1170
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$13.6K ﹤0.01%
1,163
-130
-10% -$2.29K
TDUP icon
1171
ThredUp
TDUP
$416M
$13.1K ﹤0.01%
+10,034
New +$13.8K
MAPS
1172
DELISTED
WM TECHNOLOGY INC A
MAPS
$12.9K ﹤0.01%
+12,742
New +$18.4K
PBR.A icon
1173
Petrobras Class A
PBR.A
$104B
$9.86K ﹤0.01%
+1,061
New +$11.4K
ATOS icon
1174
Atossa Therapeutics
ATOS
$25.5M
$9.5K ﹤0.01%
+1,198
New +$13.8K
WGS icon
1175
GeneDx Holdings
WGS
$2.36B
$4.97K ﹤0.01%
+571
New +$12.6K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2022 Portfolio in Review

As of Q4 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,504 positions worth $17.4B, up 14% from $15.3B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.24B of net new capital in Q4 2022, opening 416 new positions and adding to 423 existing holdings. Its largest new stake was Citigroup: 1,437,772 shares worth $65M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Energy.

On the sell side, the largest reduction was Brookfield Infrastructure Partners, an estimated $71.3M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2022 buy was Citigroup: 1,437,772 shares worth $65M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Apple in Q4 2022, an estimated $125M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2022 reduction was Brookfield Infrastructure Partners, cutting an estimated $71.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Cigna in Q4 2022, selling an estimated $39.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 30% of its $17.4B portfolio in Q4 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 416 new positions and closed 326 in Q4 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 14% quarter-over-quarter to $17.4B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2022, filed 10 Feb 2023.